Sarepta TherapeuticsDuchenne muscular dystrophyFDAUS Food and Drug AdministrationDMD
…The biotechnology company Sarepta Therapeutics has decided to suspend entirely one of its treatments for Duche…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: Sarepta Therapeutics ×
Sarepta Therapeutics
This institution is selected. Its supporting articles are shown below.